197 related articles for article (PubMed ID: 31581876)
1. Impact of Body Mass Index on the Outcomes of Catheter Ablation of Atrial Fibrillation: A European Observational Multicenter Study.
Providência R; Adragão P; de Asmundis C; Chun J; Chierchia G; Defaye P; Anselme F; Creta A; Lambiase PD; Schmidt B; Chen S; Cavaco D; Hunter RJ; Carmo J; Combes S; Honarbakhsh S; Combes N; Sousa MJ; Jebberi Z; Albenque JP; Boveda S
J Am Heart Assoc; 2019 Oct; 8(20):e012253. PubMed ID: 31581876
[TBL] [Abstract][Full Text] [Related]
2. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation.
Jongnarangsin K; Chugh A; Good E; Mukerji S; Dey S; Crawford T; Sarrazin JF; Kuhne M; Chalfoun N; Wells D; Boonyapisit W; Pelosi F; Bogun F; Morady F; Oral H
J Cardiovasc Electrophysiol; 2008 Jul; 19(7):668-72. PubMed ID: 18363693
[TBL] [Abstract][Full Text] [Related]
3. Impact of obesity on atrial fibrillation ablation: Patient characteristics, long-term outcomes, and complications.
Winkle RA; Mead RH; Engel G; Kong MH; Fleming W; Salcedo J; Patrawala RA
Heart Rhythm; 2017 Jun; 14(6):819-827. PubMed ID: 28232261
[TBL] [Abstract][Full Text] [Related]
4. Impact of body mass index on the outcome of catheter ablation of atrial fibrillation.
Glover BM; Hong KL; Dagres N; Arbelo E; Laroche C; Riahi S; Bertini M; Mikhaylov EN; Galvin J; Kiliszek M; Pokushalov E; Kautzner J; Calvo N; Blomström-Lundqvist C; Brugada J;
Heart; 2019 Feb; 105(3):244-250. PubMed ID: 30279268
[TBL] [Abstract][Full Text] [Related]
5. Impact of Type-2 Diabetes Mellitus on the Outcomes of Catheter Ablation of Atrial Fibrillation (European Observational Multicentre Study).
Creta A; Providência R; Adragão P; de Asmundis C; Chun J; Chierchia G; Defaye P; Schmidt B; Anselme F; Finlay M; Hunter RJ; Papageorgiou N; Lambiase PD; Schilling RJ; Combes S; Combes N; Albenque JP; Pozzilli P; Boveda S
Am J Cardiol; 2020 Mar; 125(6):901-906. PubMed ID: 31973808
[TBL] [Abstract][Full Text] [Related]
6. Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients.
Sivasambu B; Balouch MA; Zghaib T; Bajwa RJ; Chrispin J; Berger RD; Ashikaga H; Nazarian S; Marine JE; Calkins H; Spragg DD
J Cardiovasc Electrophysiol; 2018 Feb; 29(2):239-245. PubMed ID: 29131442
[TBL] [Abstract][Full Text] [Related]
7. Results from a multicentre comparison of cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: is cryoablation more reproducible?
Providencia R; Defaye P; Lambiase PD; Pavin D; Cebron JP; Halimi F; Anselme F; Srinivasan N; Albenque JP; Boveda S
Europace; 2017 Jan; 19(1):48-57. PubMed ID: 27267554
[TBL] [Abstract][Full Text] [Related]
8. Catheter ablation of atrial fibrillation in patients with heart failure with reduced ejection fraction: Real world experience from six European centers.
Providência R; de Asmundis C; Chun J; Chierchia G; Defaye P; Anselme F; Creta A; Lambiase PD; Schmidt B; Chen S; Hunter RJ; Combes S; Honarbakhsh S; Combes N; Sousa MJ; Jebberi Z; Albenque JP; Boveda S
J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1270-1277. PubMed ID: 31190350
[TBL] [Abstract][Full Text] [Related]
9. A prospective study evaluating the role of obesity and obstructive sleep apnea for outcomes after catheter ablation of atrial fibrillation.
Chilukuri K; Dalal D; Gadrey S; Marine JE; Macpherson E; Henrikson CA; Cheng A; Nazarian S; Sinha S; Spragg D; Berger R; Calkins H
J Cardiovasc Electrophysiol; 2010 May; 21(5):521-5. PubMed ID: 19925607
[TBL] [Abstract][Full Text] [Related]
10. Catheter Ablation for Atrial Fibrillation-Influence of Modifiable Risk Factors and Ablation Modality on Procedural Efficacy and Safety.
Sargent SR; Mladenovic JR; Liaw JJT; Siller J; Russell PL; Tung MKY; Holland DJ
Heart Lung Circ; 2024 Jun; 33(6):882-889. PubMed ID: 38570259
[TBL] [Abstract][Full Text] [Related]
11. Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation.
Bunch TJ; May HT; Bair TL; Crandall BG; Cutler MJ; Jacobs V; Mallender C; Muhlestein JB; Osborn JS; Weiss JP; Day JD
J Interv Card Electrophysiol; 2016 Sep; 46(3):259-65. PubMed ID: 27207256
[TBL] [Abstract][Full Text] [Related]
12. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.
Mohanty S; Mohanty P; Di Biase L; Bai R; Pump A; Santangeli P; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
J Am Coll Cardiol; 2012 Apr; 59(14):1295-301. PubMed ID: 22464257
[TBL] [Abstract][Full Text] [Related]
13. Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation.
Donnellan E; Wazni OM; Kanj M; Baranowski B; Cremer P; Harb S; McCarthy CP; McEvoy JW; Elshazly MB; Aagaard P; Tarakji KG; Jaber WA; Schauer PR; Saliba WI
Europace; 2019 Oct; 21(10):1476-1483. PubMed ID: 31304532
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-term risk of atrial fibrillation recurrence after first time ablation according to body mass index: a nationwide Danish cohort study.
Tønnesen J; Pallisgaard J; Ruwald MH; Rasmussen PV; Johannessen A; Hansen J; Worck RH; Zörner CR; Riis-Vestergaard L; Middelfart C; Gislason G; Hansen ML
Europace; 2023 Feb; 25(2):425-432. PubMed ID: 36480430
[TBL] [Abstract][Full Text] [Related]
15. A U-shaped relationship of body mass index on atrial fibrillation recurrence post ablation: A report from the Guangzhou atrial fibrillation ablation registry.
Deng H; Shantsila A; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Liu Y; Wei W; Fu L; Wu S; Xue Y; Lip GYH
EBioMedicine; 2018 Sep; 35():40-45. PubMed ID: 30174278
[TBL] [Abstract][Full Text] [Related]
16. Impact of obesity on catheter ablation of atrial fibrillation: Patient characteristics, procedural complications, outcomes, and quality of life.
Tabaja C; Younis A; Santageli P; Farwati M; Braghieri L; Nakagawa H; Saliba WI; Madden R; Bouscher P; Kanj M; Callahan TD; Martin D; Bhargava M; Chung M; Baranowski B; Nakhla S; Sroubek J; Lee J; Taigen T; Wazni OM; Hussein AA
J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1648-1657. PubMed ID: 37493505
[TBL] [Abstract][Full Text] [Related]
17. Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study.
Pathak RK; Elliott A; Middeldorp ME; Meredith M; Mehta AB; Mahajan R; Hendriks JM; Twomey D; Kalman JM; Abhayaratna WP; Lau DH; Sanders P
J Am Coll Cardiol; 2015 Sep; 66(9):985-96. PubMed ID: 26113406
[TBL] [Abstract][Full Text] [Related]
18. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.
Deng H; Shantsila A; Xue Y; Bai Y; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Wu S; Lip GYH
Arch Cardiovasc Dis; 2019; 112(6-7):420-429. PubMed ID: 31133543
[TBL] [Abstract][Full Text] [Related]
19. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study.
Creta A; Elliott P; Earley MJ; Dhinoja M; Finlay M; Sporton S; Chow A; Hunter RJ; Papageorgiou N; Lowe M; Mohiddin SA; Boveda S; Adragao P; Jebberi Z; Matos D; Schilling RJ; Lambiase PD; Providência R
Europace; 2021 Sep; 23(9):1409-1417. PubMed ID: 33930121
[TBL] [Abstract][Full Text] [Related]
20. The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation.
Canpolat U; Aytemir K; Yorgun H; Şahiner L; Kaya EB; Çay S; Topaloğlu S; Aras D; Oto A
Europace; 2015 Dec; 17(12):1807-15. PubMed ID: 25995388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
